


******HOT STOCK ON THE WATCHLIST FOR A SWING TRADE IN THE WEEKS TO COME, SPECULATION AND RUMORS HAVE BROUGHT IT THE ATTENTION OF MANY AND SOME ACCUMULATION HAS STARTED TO TAKE PLACE. JUST LIKE MOST BIO STOCKS, AMEX:OGEN TENDS TO MOVE VERY FAST FOR GREAT GAINS ON TRIAL AND DATA RELEASE, SO SET YOUR ALERTS FOR SPIKES. AVERAGE ANALYSTS PRICE TARGET ...
The cannabis bubble from last year, well and truly burst for NASDAQ:TLRY having ran to a post IPO price of $300 it reached a low of $34 within 1 year. The majority of cannabis stocks are in a bear market, as sentiment has turned very negative on the sector. This week TLRY has shown some signs of recovery but the stock is under pressure from all the MA'S and a...
*******HOT STOCK ON THE WATCHLIST FOR NEXT WEEK, STRENGTH HAS BEEN BUILDING IN NASDAQ:SELB SINCE JANUARY AND A BREAKOUT IS VERY POSSIBLE SOON. THE HISTOGRAM HAS GONE POSITIVE AND THE MACD IS ABOUT TO CROSS POSITIVELY, WHILE THE RSI IS AT A APEX AND LOOKS LIKE BREAKING OUT TO THE UPSIDE. ALERTS ARE SET FOR BREAK ABOVE THE 50MA WHICH IS CURRENTLY RESISTANCE BUT...
We are ignoring today's downgrade as having no significance, NYSE:CWH has been in free-fall for 2 years and despite the CEO buying shares and a hedge fund entering the stock it has failed to find a bottom. The company is on a aggressive restructuring and cost cutting strategy which will hopefully impact earnings in the next quarter. This could be a very...
NASDAQ:NEPT TODAY ANNOUNCED A 3 YEAR DEAL WITH NASDAQ:TLRY , THIS IS EXTREMELY POSITIVE AND LUCRATIVE FOR THE COMPANY, WE EXPECT THIS TO RUN MUCH HIGHER IN THE DAYS TO COME.
ALTHOUGH THE STOCK HAS JUMPED THIS WEEK, IT IS NOT TO LATE TO GET IN, BUYING PRESSURE IS IMMENSE AND THE STOCK HAS A EASY 50% UPSIDE POTENTIAL LEFT IN THE TANK, ON THE BACK OF GROWING EXPECTATION THE COMPANY WILL HAVE ITS FIRST APPROVED DRUG FOR SALE AND AT LAST GENERATE PROFITS . AVERAGE ANALYSTS PRICE TARGET $118 AVERAGE ANALYSTS RECOMMENDATION ...
This may be a little risky but we think it has a good risk reward with strong support below from channel, trend line and 100ma. Sentiment is quite mixed in the name and analysts quite split with upgrades and downgrades of estimates recently but we are bias to upside potential. AVERAGE ANALYSTS PRICE TARGET $241 AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT...
THE COMPANY HAS LOST HALF OF IT VALUE TODAY, COULD BE VIEWED AS A EXTREME REACTION TO POOR EARNINGS AND OUTLOOK AS A RESULT OF WEATHER AND TARIFFS AMONG OTHERS. OPTION TRADERS HAVE SEEN A OPPORTUNITY TO ENTER A REVERSAL TRADE WITH 6 TIMES THE USUAL CALL BUYING TODAY WITH A $15 STRIKE IN SEPT 19, SUCH ACTIVITY CAN'T BE IGNORED. COMPANY PROFILE At Home Group,...
The companies recent earnings report was horrendous as was the outlook, that alone was a good reason to discard your stock but the news that the CEO was making a abrupt departure was a real alarm bell moment. The stock has been in a rapid decline since its IPO and has followed a pattern of sizable drops, this one may be much greater so don't try and catch the...
Earnings, sales and revenue were fine but it was the mention of taffies that sent the stock into the red, its is estimated that an increase in tariffs would result in a extra $25 million cost and result in a 3-4 % drag on earnings in 2019. This is not what investors want to hear as NASDAQ:FIVE is restricted by its name when it come to passing costs onto...
===================== HOTH (Hoth Therapeutics, Inc.) Float: 3.86M Alert Price: $6.57 Target Price: $10.00 Chart Analysis Investor Presentation Website | Recent News ======================== Members, We hope you enjoyed the easy double-digit gains that today's trade idea delivered. You'll be happy to know that we have already identified an...
OUR SCANNERS HAS IDENTIFIES THE CHART OF NASDAQ:NMIH AS A VERY BULLISH BREAKOUT CONTENDER IN THE COMING DAYS. CURRENTLY CONSOLIDATING AND FORMING A BULLISH FLAG, SET ALERTS FOR A BREAK ABOVE $29 AND CONFIRM WITH STRONG VOLUME ON A POSSIBLE RETEST. AVERAGE ANALYSTS PRICE TARGET $32 AVERAGE ANALYSTS RECOMMENDATION BUY P/E RATIO 16 COMPANY PROFILE NMI...
IT HAS BEEN A DRASTIC DECLINE FOR NYSE:ANF LOSING 45% IN 1 MONTH, THIS PROVIDES A POSSIBLE OPPORTUNITY FOR A REVERSAL/BOUNCE TRADE FROM EXCEPTIONALLY OVERSOLD TERRITORY. WE EXPECT SOME MORE DOWNSIDE AND A TEST OF SUPPORT AT $15.80 OR $14.20. SELLING HAS BEGAN TO DECLINE, WITH DECREASING VOLUME AND SOME BOTTOM FEEDERS HAVE STARTED TO NIBBLE ALREADY. THE RETAIL...
THERE IS BOTH A SHORT AND LONG OPPORTUNITY IN NASDAQ:TREE , THE STOCK IS SETTING UP FOR A BREAKOUT BUT THERE IS SOME BEARISH DIVERGENCE ON THE CHART, A BREAK OF $400 BULLISH, ON THE OTHER HAND A FAILED BREAKOUT IS A FANTASTIC OPPORTUNITY TO SHORT. SHORT INTEREST 24% COMPANY PROFILE LendingTree, Inc. engages in the operation of online loan marketplace for...
===================== ANFI (Amira Nature Foods Ltd.) Float: 25.82M Alert Price: $1.05 Target Price: $6.00 Chart Analysis Investor Presentation Investor Webcast Website | Recent News ======================== Members, Our biggest NYSE-listed winner of 2019 looks ready to breakout big once again! It's time to add ANFI (Amira Nature Foods Ltd.)...
****SCANNERS HAVE ALERTED US TO THE STOCK OF NYSE:BB WITH A POSSIBLE REVERSAL TRADE IN THE COMING DAYS. WISE TO WAIT FOR CONFIRMATION FROM STRONG VOLUME, MACD CROSS AND BULLISH ENGULFING CANDLE, RSI IS ALSO RECOVERING****** SET ALERTS FOR BREAK OF $8.50 FOR MORE BULLISH ENTRY.
********HUGE POTENTIAL PROFITS ON IMPENDING BREAKOUT AFTER FORMING CAP AND HANDLE , WE AWAIT A UPTAKE IN VOLUME AND A BREAK ABOVE $59 TO CONFIRM SETUP, INDICATORS ARE ALL BULLISH, LOOKS LIKE A GEM***** AVERAGE ANALYSTS PRICE TARGET $67 AVERAGE ANALYST RECOMMENDATION BUY COMPANY PROFILE Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages...
*****Purely based on technical setup in NASDAQ:CPRT looks like a very good possibility of a major breakout in the coming days set alert for $72.50. ********* COMPANY PROFILE Copart, Inc. engages in the provision of online auctions and vehicle remarketing services. It provides vehicle sellers with a full range of services to process and sell vehicles primarily...